Booth; Richard John
Patent Applications and Registrations
Patent applications and USPTO patent grants for Booth; Richard John.The latest application filed is for "2-(pyridin-2-ylamino)-pyrido [2,3 d]pyrimidin-7-ones".
- Booth; Richard John - Ann Arbor MI
- BOOTH, RICHARD JOHN - YPSILANTI MI
| Patent | Date |
|---|---|
| 2-(pyridin-2-ylamino)-pyrido[2,3-D]pyrimidin-7-ones Grant RE47,739 - Barvian , et al. Nov | 2019-11-26 |
| 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones Grant 7,456,168 - Barvian , et al. November 25, 2 | 2008-11-25 |
| 2-(pyridin-2-ylamino)-pyrido [2,3 D]pyrimidin-7-ones App 20070179118 - Barvian; Mark ; et al. | 2007-08-02 |
| 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones Grant 7,208,489 - Barvian , et al. April 24, 2 | 2007-04-24 |
| Inhibitors of checkpoint kinases (Wee1 and Chk1) Grant 7,094,798 - Booth , et al. August 22, 2 | 2006-08-22 |
| Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors Grant 7,053,070 - Booth , et al. May 30, 2 | 2006-05-30 |
| Inhibitors of checkpoint kinases (Wee1 and Chk1) App 20050250836 - Booth, Richard John ; et al. | 2005-11-10 |
| 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones Grant 6,936,612 - Barvian , et al. August 30, 2 | 2005-08-30 |
| 2-(Pyridin-2-ylamino)-pyrido [2,3-D]pyrimidin-7-ones App 20050137214 - Barvian, Mark ; et al. | 2005-06-23 |
| Tricyclic compounds with antiviral activity App 20050075332 - Booth, Richard John ; et al. | 2005-04-07 |
| Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereof App 20050037476 - Baker, Edward Neill ; et al. | 2005-02-17 |
| Pyridopyrimidinone derivatives for treatment of neurodegenerative disease App 20040224958 - Booth, Richard John ; et al. | 2004-11-11 |
| Tricyclic compounds and method of treating herpes virus Grant 6,800,656 - Booth , et al. October 5, 2 | 2004-10-05 |
| Amide inhibitors of microsomal triglyceride transfer protein Grant 6,780,883 - Booth , et al. August 24, 2 | 2004-08-24 |
| Benzenesulfonamide derivatives and their use as MEK inhibitors Grant 6,750,217 - Barrett , et al. June 15, 2 | 2004-06-15 |
| Tricyclic compounds and method of treating herpes virus App 20030229073 - Booth, Richard John ; et al. | 2003-12-11 |
| 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones App 20030149001 - Barvian, Mark ; et al. | 2003-08-07 |
| Benzenesulfonamide derivatives and their use as MEK inhibitors App 20030092748 - Barrett, Stephen Douglas ; et al. | 2003-05-15 |
| Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors App 20030073668 - Booth, Richard John ; et al. | 2003-04-17 |
| Amide inhibitors of microsomal triglyceride transfer protein App 20020156281 - Booth, Richard John ; et al. | 2002-10-24 |
| Benzenesulfonamide derivatives and their use as MEK inhibitors Grant 6,440,966 - Barrett , et al. August 27, 2 | 2002-08-27 |
| Peptidyl calcium channel blockers Grant 6,423,689 - Booth , et al. July 23, 2 | 2002-07-23 |
| Aryl Alkenamides Derivatives As Mcp-1 Antagonists App 20020028833 - BOOTH, RICHARD JOHN ; et al. | 2002-03-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 